Skip to main content

10x Genomics, Inc 10-Q for FY2026 Q2

10x Genomics, Inc. (TXG)

10-Q 2026-08-07 For: 2026-06-30
View Original
Added on August 07, 2026

About this 10-Q

10x Genomics, Inc filed this 10-Q on August 7, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).

Headline figures

Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$151.04M
down 12.6% from $172.91M a year earlier
Net loss
$17.93M
compared with net income of $34.54M a year earlier
Diluted EPS
-$0.14
compared with $0.28 a year earlier